Outlook Therapeutics
OTLK
OTLK
73 hedge funds and large institutions have $45.3M invested in Outlook Therapeutics in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 21 reducing their positions, and 9 closing their positions.
Holders
73
Holders Change
+3
Holders Change %
+4.29%
% of All Funds
1.16%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
14
Increased
23
Reduced
21
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VF
1
Vista Finance
Clayton,
Missouri
|
$1.75M |
| 2 |
2
Nuveen Asset Management
Chicago,
Illinois
|
$1.92M |
| 3 |
3
BlackRock
New York
|
$11.9M |
| 4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$3.32M |
| 5 |
5
Northern Trust
Chicago,
Illinois
|
$1.75M |
Top Sellers
| 1 |
1
Two Sigma Investments
New York
|
$420K |
| 2 |
2
Renaissance Technologies
New York
|
$1.3M |
| 3 |
3
Two Sigma Advisers
New York
|
$964K |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$10M |
| 5 |
5
Millennium Management
New York
|
$636K |
